These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6130605)

  • 21. The neuroanatomy and pharmacology of the nucleus locus coeruleus.
    Grant SJ; Redmond DE
    Prog Clin Biol Res; 1981; 71():5-27. PubMed ID: 6276901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Involvement of neurosteroids in normal and pathological behaviour].
    Martín-García E; Darbra S; Pallarès M
    Rev Neurol; 2007 Jun 1-15; 44(11):661-76. PubMed ID: 17557223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of brain noradrenergic system and the hypothalamic-pituitary-adrenal (HPA) axis in man.
    Young EA; Abelson JL; Cameron OG
    Psychoneuroendocrinology; 2005 Sep; 30(8):807-14. PubMed ID: 15896919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stress, neuropsychiatric disorders and immunological effects exerted by benzodiazepines.
    Covelli V; Maffione AB; Nacci C; Tatò E; Jirillo E
    Immunopharmacol Immunotoxicol; 1998 May; 20(2):199-209. PubMed ID: 9653667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transgenic mice overexpressing the full-length neurotrophin receptor TrkC exhibit increased catecholaminergic neuron density in specific brain areas and increased anxiety-like behavior and panic reaction.
    Dierssen M; Gratacòs M; Sahún I; Martín M; Gallego X; Amador-Arjona A; Martínez de Lagrán M; Murtra P; Martí E; Pujana MA; Ferrer I; Dalfó E; Martínez-Cué C; Flórez J; Torres-Peraza JF; Alberch J; Maldonado R; Fillat C; Estivill X
    Neurobiol Dis; 2006 Nov; 24(2):403-18. PubMed ID: 16963267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of chlordiazepoxide on footshock- and corticotropin-releasing factor-induced increases in cortical and hypothalamic norepinephrine secretion in rats.
    Swiergiel AH; Li Y; Wei ZY; Dunn AJ
    Neurochem Int; 2008 May; 52(6):1220-5. PubMed ID: 18280616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Psychopharmacology and clinical aspects of benzodiazepine dependence].
    Apelt S; Schmauss C; Emrich HM
    Fortschr Neurol Psychiatr; 1992 Mar; 60(3):104-9. PubMed ID: 1349546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gamma-aminobutyric acidA receptor subunits in the mediation of selective drug action.
    Enna SJ
    Curr Opin Neurol Neurosurg; 1993 Aug; 6(4):597-601. PubMed ID: 8104553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [How far has the search for endogenous ligands of benzodiazepine receptors progressed?].
    Hamon M
    Encephale; 1983; 9(4 Suppl 2):131B-142B. PubMed ID: 6144508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in endocrine and neurochemical profiles in neonatal pigs prenatally exposed to increased maternal cortisol.
    Kanitz E; Otten W; Tuchscherer M
    J Endocrinol; 2006 Oct; 191(1):207-20. PubMed ID: 17065404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anxiolytic-like effects of the corticotropin-releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats.
    Lelas S; Wong H; Li YW; Heman KL; Ward KA; Zeller KL; Sieracki KK; Polino JL; Godonis HE; Ren SX; Yan XX; Arneric SP; Robertson DW; Hartig PR; Grossman S; Trainor GL; Taub RA; Zaczek R; Gilligan PJ; McElroy JF
    J Pharmacol Exp Ther; 2004 Apr; 309(1):293-302. PubMed ID: 14742750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From ion currents to genomic analysis: recent advances in GABAA receptor research.
    Rabow LE; Russek SJ; Farb DH
    Synapse; 1995 Nov; 21(3):189-274. PubMed ID: 8578436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The neurochemical profile of the caudate nucleus in the anxiolytic action of benzodiazepine and nonbenzodiazepine tranquilizers on different models of anxiety].
    Talalaenko AN; Gordienko DV; Markova OP
    Eksp Klin Farmakol; 2000; 63(1):14-8. PubMed ID: 10763103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anxiolytic profiles.
    Gershon S; Eison AS
    J Clin Psychiatry; 1983 Nov; 44(11 Pt 2):45-57. PubMed ID: 6139369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benzodiazepine recognition site ligands: biochemistry and pharmacology.
    Adv Biochem Psychopharmacol; 1983; 38():1-260. PubMed ID: 6142597
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.
    Palucha A; Pilc A
    Pharmacol Ther; 2007 Jul; 115(1):116-47. PubMed ID: 17582504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological peripheral correlates of anxiety.
    Boulenger JP; Uhde TW
    Encephale; 1982; 8(2):119-30. PubMed ID: 7106044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New anxiolytics in development.
    Mosconi M; Chiamulera C; Recchia G
    Int J Clin Pharmacol Res; 1993; 13(6):331-44. PubMed ID: 7916335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Increased activity of stress-regulating systems in Alzheimer disease].
    Hoogendijk WJ; Meynen G; Feenstra MG; Eikelenboom P; Kamphorst W; Swaab DF
    Tijdschr Gerontol Geriatr; 2001 Feb; 32(1):17-23. PubMed ID: 11293840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relation between the nature of psychotropic effects on emotional reactivity and behavior in stress situations and the status of the brain's catecholaminergic systems].
    Bondarenko NA; Val'dman AV; Kamysheva VA
    Biull Eksp Biol Med; 1981 Jul; 92(7):35-8. PubMed ID: 6117338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.